埃可病毒7与其受体衰变加速因子（CD55）之间的相互作用：A颗粒形成中二级细胞因子的证据。
Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.
作者信息
Powell R M, Ward T, Evans D J, Almond J W
机构信息
School of Animal and Microbial Sciences, University of Reading, Whiteknights, United Kingdom.
出版信息
J Virol. 1997 Dec;71(12):9306-12. doi: 10.1128/JVI.71.12.9306-9312.1997.
Abstract
Soluble forms of decay-accelerating factor (DAF) (CD55), the receptor for echovirus 7, were synthesized in the yeast Pichia pastoris. Purified recombinant protein containing SCR domains 2, 3, and 4, but lacking the serine/threonine rich region, was shown to block infection of susceptible cells by echovirus 7. In contrast to the situation with poliovirus and its receptor, the neutralization of echovirus 7 by soluble DAF was completely reversible and did not lead to the formation of 135S A-particles. Binding of virus to susceptible cells, by contrast, did lead to the formation of A particles, mainly from virus that had been internalized. The data suggest that a secondary factor(s) may contribute to A-particle formation and uncoating of echovirus 7.
摘要
衰变加速因子（DAF，即CD55）的可溶性形式，作为埃可病毒7的受体，在毕赤酵母中合成。纯化后的重组蛋白包含第2、3和4个短共识重复序列（SCR）结构域，但缺少富含丝氨酸/苏氨酸的区域，该蛋白可阻断埃可病毒7对易感细胞的感染。与脊髓灰质炎病毒及其受体的情况不同，可溶性DAF对埃可病毒7的中和作用是完全可逆的，且不会导致135S A颗粒的形成。相比之下，病毒与易感细胞的结合确实会导致A颗粒的形成，主要来自内化的病毒。数据表明，可能有第二个因素促成了埃可病毒7的A颗粒形成和解衣壳过程。
相似文献
1
Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.
J Virol. 1997 Dec;71(12):9306-12. doi: 10.1128/JVI.71.12.9306-9312.1997.
2
Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55.
J Biol Chem. 1998 Nov 13;273(46):30443-7. doi: 10.1074/jbc.273.46.30443.
3
Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
J Gen Virol. 2002 Jan;83(Pt 1):45-52. doi: 10.1099/0022-1317-83-1-45.
4
Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.
J Virol. 1998 Nov;72(11):9380-3. doi: 10.1128/JVI.72.11.9380-9383.1998.
5
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
J Gen Virol. 2005 May;86(Pt 5):1369-1377. doi: 10.1099/vir.0.80669-0.
6
Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
J Virol. 2002 Aug;76(15):7694-704. doi: 10.1128/jvi.76.15.7694-7704.2002.
7
Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
J Virol. 2005 Jan;79(1):655-60. doi: 10.1128/JVI.79.1.655-660.2005.
8
Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.
J Virol. 1995 Sep;69(9):5497-501. doi: 10.1128/JVI.69.9.5497-5501.1995.
9
Interaction of decay-accelerating factor with echovirus 7.
J Virol. 2010 Dec;84(24):12665-74. doi: 10.1128/JVI.00837-10. Epub 2010 Sep 29.
10
Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59.
J Gen Virol. 2000 May;81(Pt 5):1393-401. doi: 10.1099/0022-1317-81-5-1393.
引用本文的文献
1
Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B.
Cell. 2019 May 30;177(6):1553-1565.e16. doi: 10.1016/j.cell.2019.04.035. Epub 2019 May 16.
2
Neutralizing antibodies can initiate genome release from human enterovirus 71.
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2134-9. doi: 10.1073/pnas.1320624111. Epub 2014 Jan 27.
3
The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
J Virol. 2012 Dec;86(23):12571-81. doi: 10.1128/JVI.01592-12. Epub 2012 Sep 12.
4
Echovirus 7 entry into polarized intestinal epithelial cells requires clathrin and Rab7.
mBio. 2012 Apr 10;3(2). doi: 10.1128/mBio.00304-11. Print 2012.
5
Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells.
J Virol. 2011 Dec;85(23):12376-86. doi: 10.1128/JVI.00016-11. Epub 2011 Sep 14.
6
Interaction of decay-accelerating factor with echovirus 7.
J Virol. 2010 Dec;84(24):12665-74. doi: 10.1128/JVI.00837-10. Epub 2010 Sep 29.
7
Interaction of decay-accelerating factor with coxsackievirus B3.
J Virol. 2007 Dec;81(23):12927-35. doi: 10.1128/JVI.00931-07. Epub 2007 Sep 5.
8
A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen.
J Biol Chem. 2006 Sep 29;281(39):29120-30. doi: 10.1074/jbc.M605681200. Epub 2006 Aug 1.
9
Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
J Virol. 2005 Sep;79(18):12016-24. doi: 10.1128/JVI.79.18.12016-12024.2005.
10
Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus.
J Virol. 2005 Jul;79(13):8519-34. doi: 10.1128/JVI.79.13.8519-8534.2005.
本文引用的文献
1
PURIFICATION AND CHEMICAL ANALYSIS OF THE ERYTHROCYTE RECEPTOR FOR HEMAGGLUTINATING ENTEROVIRUSES.
Virology. 1964 Apr;22:580-90. doi: 10.1016/0042-6822(64)90080-7.
2
Early interactions between poliovirus and ERK cells: some observations on the nature and significance of the rejected particles.
Virology. 1962 Oct;18:212-23. doi: 10.1016/0042-6822(62)90007-7.
3
Irreversible eclipse of poliovirus by HeLa cells.
Virology. 1962 Feb;16:163-76. doi: 10.1016/0042-6822(62)90292-1.
4
The adsorption and early fate of purified poliovirus in HeLa cells.
Virology. 1961 Apr;13:439-47. doi: 10.1016/0042-6822(61)90275-6.
5
Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
J Virol. 1997 Jun;71(6):4736-43. doi: 10.1128/JVI.71.6.4736-4743.1997.
6
The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
J Exp Med. 1996 Sep 1;184(3):1185-9. doi: 10.1084/jem.184.3.1185.
7
The poliovirus receptor: a hook, or an unzipper?
Structure. 1996 Jul 15;4(7):769-73. doi: 10.1016/s0969-2126(96)00083-4.
8
The poliovirus 135S particle is infectious.
J Virol. 1996 Oct;70(10):7125-31. doi: 10.1128/JVI.70.10.7125-7131.1996.
9
Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells.
Infect Immun. 1996 Jun;64(6):1918-28. doi: 10.1128/iai.64.6.1918-1928.1996.
10
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
Science. 1996 Jun 28;272(5270):1955-8. doi: 10.1126/science.272.5270.1955.
Zotero 插件